UTMD News and Press, Utah Medical Products Inc. From 01/31/23

SALT LAKE CITY, UT, Jan. 31, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Utah Medical Products, Inc. (Nasdaq: UTMD) finished the calendar year with a solid fourth quarter (4Q) performance, which allowed financial results for the year 2022 exceeding management’s beginning of year...

Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The Dividend Champions list is a m...

Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Dividend C...

Summary All stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. They have an average increase of 6% and a median increase of 5.8%. There are twenty-one increases for next week, up from eight last week. Companies...

Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The Dividend Champions list ...

Utah Medical Products ( NASDAQ: UTMD ) declares $0.295/share quarterly dividend , 1.7% increase from prior dividend of $0.290. Payable Jan. 4; for shareholders of record Dec. 16; ex-div Dec. 15. See UTMD Dividend Scorecard, Yield Chart, & Dividend Growth. ...

SALT LAKE CITY, UT / ACCESSWIRE / November 1, 2022 / Utah Medical Products, Inc. (Nasdaq:UTMD) announces that its Board of Directors approved a quarterly cash dividend of twenty-nine and one-half cents ($.295) per share of common stock payable on January 4, 2023 to shareholders of record at ...

Utah Medical Products press release ( NASDAQ: UTMD ): Q3 GAAP EPS of $1.178. Revenue of $12.95M (+3.0% Y/Y). For further details see: Utah Medical Products GAAP EPS of $1.178, revenue of $12.95M

SALT LAKE CITY, UT, Oct. 25, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire - In the third calendar quarter (3Q) of 2022, despite significant cost inflation, supply chain disruption, litigation expenses and negative impact of a stronger U.S. Dollar on foreign currency sales, Utah Medical Pro...

Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. For further details see: Divi...